March 5, 2026
1 min read

dsm-firmenich expands HMO portfolio with regulatory approvals in Asia

Ingredients supplier dsm-firmenich is expanding its human milk oligosaccharides (HMOs) portfolio in China, Malaysia, and Thailand, making it one of the first companies to provide secure access to HMOs in these countries. The company’s 3’-sialyllactose (3’-SL) sodium salt ingredient, commercially known as Glycare 3SL 9001, received regulatory approval in all three markets for use in early-life nutrition.

Leave a Reply

Your email address will not be published.

Previous Story

Some US Medical Schools to Teach Nutrition Under Government Deal

Next Story

Managing cattle nutrition during pasture recovery

Previous Story

Some US Medical Schools to Teach Nutrition Under Government Deal

Next Story

Managing cattle nutrition during pasture recovery

Latest from Blog

Go toTop